Revvity Free Cash Flow 2010-2025 | RVTY
Revvity annual/quarterly free cash flow history and growth rate from 2010 to 2025. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
- Revvity free cash flow for the quarter ending March 31, 2025 was 541.65, a year-over-year.
- Revvity free cash flow for the twelve months ending March 31, 2025 was , a year-over-year.
- Revvity annual free cash flow for 2024 was $0.542B, a 5369.01% increase from 2023.
- Revvity annual free cash flow for 2023 was $0.01B, a 98.33% decline from 2022.
- Revvity annual free cash flow for 2022 was $0.594B, a 55.15% decline from 2021.
| Revvity Annual Free Cash Flow | |
|---|---|
| 2024 | 541.65 |
| 2023 | 9.90 |
| 2022 | 594.18 |
| 2021 | 1,324.73 |
| 2020 | 832.82 |
| 2019 | 287.69 |
| 2018 | 255.81 |
| 2017 | 250.46 |
| 2016 | 339.91 |
| 2015 | 258.88 |
| 2014 | 256.98 |
| 2013 | 171.81 |
| 2012 | 109.77 |
| 2011 | 194.74 |
| 2010 | 141.62 |
| 2009 | 123.21 |
| Revvity Quarterly Free Cash Flow | |
|---|---|
| 2024-12-31 | 541.65 |
| 2024-09-30 | 391.88 |
| 2024-06-30 | 266.31 |
| 2024-03-31 | 129.72 |
| 2023-12-31 | 9.90 |
| 2023-09-30 | -162.59 |
| 2023-06-30 | -106.75 |
| 2023-03-31 | 42.52 |
| 2022-12-31 | 594.18 |
| 2022-09-30 | 486.81 |
| 2022-06-30 | 334.23 |
| 2022-03-31 | 256.25 |
| 2021-12-31 | 1,324.73 |
| 2021-09-30 | 1,017.55 |
| 2021-06-30 | 726.69 |
| 2021-03-31 | 459.19 |
| 2020-12-31 | 832.82 |
| 2020-09-30 | 355.11 |
| 2020-06-30 | 163.32 |
| 2020-03-31 | 39.56 |
| 2019-12-31 | 287.69 |
| 2019-09-30 | 95.18 |
| 2019-06-30 | 5.63 |
| 2019-03-31 | -24.64 |
| 2018-12-31 | 255.81 |
| 2018-09-30 | 129.20 |
| 2018-06-30 | 18.82 |
| 2018-03-31 | -37.21 |
| 2017-12-31 | 250.46 |
| 2017-09-30 | 138.00 |
| 2017-06-30 | 90.38 |
| 2017-03-31 | 47.76 |
| 2016-12-31 | 339.91 |
| 2016-09-30 | 177.48 |
| 2016-06-30 | 133.41 |
| 2016-03-31 | 25.38 |
| 2015-12-31 | 258.88 |
| 2015-09-30 | 144.05 |
| 2015-06-30 | 91.04 |
| 2015-03-31 | 33.18 |
| 2014-12-31 | 256.98 |
| 2014-09-30 | 162.82 |
| 2014-06-30 | 107.66 |
| 2014-03-31 | 61.69 |
| 2013-12-31 | 171.81 |
| 2013-09-30 | 107.54 |
| 2013-06-30 | 15.94 |
| 2013-03-31 | -0.90 |
| 2012-12-31 | 109.77 |
| 2012-09-30 | 88.30 |
| 2012-06-30 | 80.48 |
| 2012-03-31 | 10.31 |
| 2011-12-31 | 194.74 |
| 2011-09-30 | 117.83 |
| 2011-06-30 | 78.58 |
| 2011-03-31 | 34.97 |
| 2010-12-31 | 141.62 |
| 2010-09-30 | 123.46 |
| 2010-06-30 | 117.24 |
| 2010-03-31 | 41.89 |
| 2009-12-31 | 123.21 |
| 2009-09-30 | 70.80 |
| 2009-06-30 | 38.58 |
| 2009-03-31 | 9.82 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.032B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| Natera (NTRA) | United States | $20.018B | 0.00 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Doximity (DOCS) | United States | $9.934B | 51.66 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| HealthEquity (HQY) | United States | $7.311B | 35.97 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |